Flotek Receives EPA Approval For VeraCAL Flare Monitoring At Petroleum Refineries

EPA approval opens refinery compliance market for Flotek's VeraCAL, but commercial impact unproven.

What the company is saying

Flotek Industries, Inc. announces that the U.S. Environmental Protection Agency has approved its proprietary VeraCAL optical system as an alternative to gas chromatography for measuring flare vent gas composition and net heating value under 40 CFR Part 63, Subpart CC (MACT CC). The company frames this as a significant regulatory milestone, emphasizing that the approval is published as Alternative Test Method 163 (ALT-163) and marks VeraCAL's second EPA alternative-method approval after an initial approval in July 2024. CEO Dr. Ryan Ezell positions the news as a catalyst for expanding the Data Analytics business, highlighting VeraCAL's potential to simplify refinery flare monitoring and compliance. The narrative stresses VeraCAL's technical differentiation—continuous, near real-time measurement without carrier gas or chromatographic separation—and the scale of the U.S. refining market, which included 130 operable refineries as of January 1, 2026. Flotek also references recent EPA rule changes that extend similar monitoring requirements to chemical manufacturing and gasoline distribution, suggesting a broader addressable market. The company underscores its innovation credentials with a portfolio of more than 130 patents, over two decades of field and laboratory data, and a presence in more than 59 countries. The tone is optimistic, with repeated forward-looking statements about market opportunity and business growth, but no mention of current sales, contracts, or financial performance.

What the data suggests

The only realised, verifiable achievement is EPA approval of VeraCAL as Alternative Test Method 163, which is a concrete regulatory milestone. VeraCAL previously received its first EPA alternative-method approval in July 2024, indicating a pattern of regulatory acceptance. The U.S. refining industry comprises 130 operable refineries as of January 1, 2026, defining the potential domestic customer base for VeraCAL under MACT CC. Flotek claims a portfolio of more than 130 patents and operational experience spanning over two decades, and states a global reach in more than 59 countries. The announcement does not provide any financial metrics, sales volumes, customer contracts, or adoption rates for VeraCAL or the Data Analytics segment. No technical performance data, cost-benefit analysis, or customer testimonials are disclosed to substantiate claims about VeraCAL's operational advantages. The company asserts that recent EPA rulemakings expand the addressable market to chemical manufacturing and gasoline distribution, but does not quantify the impact or cite specific regulatory texts. All statements about business expansion, market penetration, and growth are forward-looking and unsupported by commercial evidence in this release.

Analysis

The announcement highlights a genuine regulatory milestone: EPA approval of VeraCAL as an alternative test method, which is a concrete, realised achievement. However, the tone is notably optimistic about the business impact, with multiple forward-looking statements about expanding the Data Analytics business, serving new markets, and growth opportunities. No financial metrics, customer contracts, or adoption figures are disclosed, so the actual commercial impact remains unproven. The gap between narrative and evidence lies in the leap from regulatory approval to implied business expansion and revenue growth, which are not substantiated by operational or financial data. The absence of capital outlay or immediate earnings claims means capital intensity is not a concern here. The hype is moderate: the language inflates the significance of the approval by projecting future business benefits without supporting data.

Risk flags

• ●Commercial adoption risk is high: while EPA approval is necessary for market entry, no refinery customers, contracts, or adoption figures are disclosed, so actual revenue impact remains speculative.
• ●Execution risk exists in converting regulatory approval into sales: refinery operators may be slow to switch from incumbent technologies, and VeraCAL's operational advantages are asserted but not validated with performance or cost data.
• ●Regulatory dependency risk: future changes to EPA rules or the scope of MACT CC could alter the addressable market or require further product adaptation, potentially undermining the current approval's value.

Bottom line

Flotek Industries has secured a second EPA alternative-method approval for its VeraCAL optical system, granting it regulatory legitimacy for refinery flare monitoring under MACT CC and positioning it to target 130 U.S. refineries as of January 1, 2026. The company highlights this as a major step for its Data Analytics segment and points to broader market potential from recent EPA rule changes. However, the announcement provides no evidence of customer traction, signed contracts, or financial impact, and all claims of business growth remain aspirational. The practical takeaway is that regulatory approval is a necessary but not sufficient condition for commercial success; investors should look for future disclosures of customer wins, revenue attributable to VeraCAL, or adoption rates to validate the business case. Until such evidence emerges, the commercial and financial impact of this milestone is unproven.

Announcement summary

(NYSE:FTK) Flotek Industries, Inc. announced that the U.S. Environmental Protection Agency (EPA) has approved its proprietary VeraCAL optical system as an alternative to gas chromatography for measuring flare vent gas composition and net heating value (NHV) under 40 CFR Part 63, Subpart CC, National Emission Standards for Hazardous Air Pollutants From Petroleum Refineries (MACT CC). The EPA approval is published as Alternative Test Method 163 (ALT-163). This marks VeraCAL's second EPA alternative-method approval, following its initial approval in July 2024. Dr. Ryan Ezell, Chief Executive Officer of Flotek, stated that this approval is an important step in expanding the company's Data Analytics business. VeraCAL is designed to provide continuous, near real-time measurements for flare monitoring without the need for carrier gas or chromatographic separation. The U.S. refining industry included 130 operable refineries as of January 1, 2026. Recent EPA rulemakings have extended refinery-style flare monitoring requirements to certain chemical manufacturing and gasoline distribution operations. Flotek's Data Analytics segment is focused on innovation in flare compliance measurement through VeraCAL technology and monitoring services. The company believes the new EPA approval strengthens its position in compliance measurement and creates opportunities to serve refinery customers, broaden its customer base, and grow through near real-time data solutions. Flotek leverages a portfolio of more than 130 patents and over two decades of field and laboratory data. The company has a global presence in more than 59 countries. Flotek's common shares are traded on the New York Stock Exchange under the ticker symbol "FTK."

Disagree with this article?